Hematologic Oncology Update
Un pódcast de Research To Practice
561 Episodo
-
HOU1 2016 | Interview with Rafael Fonseca, MD
Publicado: 4/8/2016 -
HOU1 2016 | Interview with John P Leonard, MD
Publicado: 4/8/2016 -
HOU1 2016 | CME Information and Program PDF
Publicado: 4/8/2016 -
MTPMDS1 2016 | Case discussion: An 80-year-old woman with MDS and a history of rheumatoid arthritis (Dr Morganstein)
Publicado: 3/8/2016 -
MTPMDS1 2016 | Case discussion: A 62-year-old man with 20q minus MDS (Dr Brenner)
Publicado: 3/8/2016 -
MTPMDS1 2016 | Case discussion: A 31-year-old woman with MDS in her first trimester of pregnancy (Dr Rupard)
Publicado: 3/8/2016 -
MTPMDS1 2016 | Case discussion: A 78-year-old man with a hemoglobin of 4 and a bone marrow biopsy compatible with MDS (Dr Morganstein)
Publicado: 3/8/2016 -
MTPMDS1 2016 | Case discussion: A 58-year-old woman who is a Jehovah's Witness with a hemoglobin of 4.1 and a bone marrow biopsy consistent with MDS (Dr Rupard)
Publicado: 3/8/2016 -
MTPMDS1 2016 | Case discussion: An 88-year-old man with high-risk MDS (Dr Brenner)
Publicado: 3/8/2016 -
MTPMDS1 2016 | Clinical trials of checkpoint inhibitors in MDS
Publicado: 3/8/2016 -
MTPMDS1 2016 | Selection of patients who will benefit from lenalidomide
Publicado: 3/8/2016 -
MTPMDS1 2016 | Five- versus 7-day therapy with azacitidine
Publicado: 3/8/2016 -
MTPMDS1 2016 | Choice of hypomethylating agent in MDS
Publicado: 3/8/2016 -
MTPMDS1 2016 | Iron chelation therapy in MDS managemen
Publicado: 3/8/2016 -
MTPMDS1 2016 | Use of erythropoiesis-stimulating agents and G-CSF in MD
Publicado: 3/8/2016 -
MTPMDS1 2016 | Prognostic scoring systems in MDS
Publicado: 3/8/2016 -
MTPMDS1 2016 | CME Information and Program PDF
Publicado: 2/8/2016 -
Community Questions 15 | Interview with Michael E Williams, MD, ScM
Publicado: 10/5/2016 -
Community Questions 15 | Interview with Sonali M Smith, MD
Publicado: 10/5/2016 -
Community Questions 15 | Interview with Irene M Ghobrial, MD
Publicado: 10/5/2016
Featuring one-on-one interviews conducted by Dr Neil Love, this series provides medical oncologists with access to an array of important perspectives and information on relevant advances in the treatment of hematologic cancer to facilitate optimal patient care.
